
[Replay] - AI and Dermato-Oncology: Current Innovations and Future Directions
During the latest International Forum of Dermatology that we organized around the thematic "Inventing the Future of Dermatology," many leading and renowned dermatology experts shared their insights on this topic.
Discover below the session dedicated to AI & DERMATO-ONCOLOGY.
Part 1 - Promises and Limitations of AI in Dermato Oncology

What you'll learn:
AI is rapidly advancing in dermato-oncology, with strong performance in skin lesion diagnostics. The central issue is how to integrate these tools responsibly into everyday clinical practice. Artificial intelligence should not be perceived as a substitute for clinical judgment, but as an extension of professional expertise, enhancing diagnostic confidence and early skin cancer detection.
Part 2 - AI in Clinical Practice for Dermato Oncology

What you'll learn:
- Non-invasive imaging technologies (VECTRA, dermoscopy, LC-OCT) combined with AI are transforming early skin cancer detection and management.
- Multimodal imaging plus AI can improve diagnostic accuracy and support decisions for melanoma, basal cell carcinoma, and actinic keratoses. Drawing on real-world experience from an AI-assisted screening center, the talk examines both the potential and limits of these tools, including trust and workflow issues—and asks whether they can truly be relied on in daily practice.
Part 3 - Cutaneous Adverse Events in Cancer Therapy

What you'll learn:
Artificial intelligence can enhance the management of anticancer therapy–related skin toxicities by enabling risk prediction, earlier detection, standardized assessment, and remote patient monitoring, thereby supporting more preventive, precise, and patient-centered oncodermatologic care without replacing clinical expertise.
Watch the replay
Interested in our news?
Discover those of our other brands.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.



